ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Silk Road Medical, Inc.
NEW YORK, June 18, 2024 /PRNewswire/ — Rowley Law PLLC is investigating potential securities law violations by Silk Road Medical, Inc. (NASDAQ: SILK) and its board of directors concerning the proposed acquisition of the company by Boston Scientific Corporation (NYSE: BSX). Stockholders will receive $27.50 for each share of Silk Road Medical stock that they hold. The transaction is valued at approximately $1.26 billion and is expected to close in the second half of 2024.